Tirzepatide SDV (Peplogix)

Product Description
Tirzepatide SDV Research Peptide (Dual GLP-1 / GIP, Single Dose Vials)
Size: Lyophilized Vial (10mg, 20mg, 40mg, 60mg)
Purity: >99% (Third-Party Tested)
Documentation: Batch-specific Certificate of Analysis (COA) available for every lot.

Product Overview
Tirzepatide is a dual GLP-1 and GIP receptor agonist widely cited in metabolic, weight-management, and endocrine research. This single dose vial (SDV) presentation supplies four individually sealed vials per pack for protocols that require single-use handling.

Every vial is manufactured under strict quality-control standards and independently verified by accredited third-party laboratories. A batch-specific Certificate of Analysis (COA) accompanies every order to confirm purity, molecular identity, and batch-to-batch consistency.

Key Features & Research Profiles
Metabolic Research Focus: A benchmark dual-receptor agonist supplied in single-use vials for controlled handling.
Rigorous Synthesis Controls: Produced under strict protocols to limit variables and support reproducible experimental data.
Accredited Verification: Full transparency with independent, third-party testing and batch-specific reporting.

Specifications & Handling
Application: For research use only. Not for human consumption.
Storage: Store at -20°C upon receipt. Protect from light and moisture. The lyophilized format maintains structural stability at room temperature for brief transit windows.